SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply
File(s)Letter B to Lancet GH v2.docx (31.24 KB)
Accepted version
Author(s)
Alexander, J
Kennedy, NA
Lees, CW
Ahmad, T
Powell, N
Type
Journal Article
Date Issued
2022-07
Date Acceptance
2021-05-20
ISSN
2468-1253
Publisher
Elsevier
Start Page
523
End Page
524
Journal / Book Title
The Lancet Gastroenterology and Hepatology
Volume
6
Issue
7
Copyright Statement
© 2021 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/
Sponsor
Pfizer Limited
Identifier
https://www.sciencedirect.com/science/article/pii/S2468125321001941?via%3Dihub
Grant Number
66798527
Subjects
COVID-19
COVID-19 Vaccines
Gastroenterology
Humans
Inflammatory Bowel Diseases
SARS-CoV-2
Vaccination
British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group
Humans
Inflammatory Bowel Diseases
Vaccination
Gastroenterology
COVID-19
SARS-CoV-2
COVID-19 Vaccines
Publication Status
Published
Date Publish Online
2021-06-10